butabarbital decreases effects of sufentanil SL by impacting hepatic/intestinal enzyme CYP3A4 metabolism. Modify Therapy/Check Intently. Coadministration of CYP3A4 inducers may possibly reduce sufentanil ranges and efficacy, quite possibly precipitating withdrawal syndrome in people who've creat